- Home
- NWE vs CPRX Comparison
NWE vs CPRX Comparison
Compare NWE & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWE
- CPRX
- Stock Information
- Founded
- NWE 1923
- CPRX 2002
- Country
- NWE United States
- CPRX United States
- Employees
- NWE N/A
- CPRX N/A
- Industry
- NWE Power Generation
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- NWE Utilities
- CPRX Health Care
- Exchange
- NWE Nasdaq
- CPRX Nasdaq
- Market Cap
- NWE 3.5B
- CPRX 2.9B
- IPO Year
- NWE N/A
- CPRX 2006
- Fundamental
- Price
- NWE $68.25
- CPRX $23.68
- Analyst Decision
- NWE Hold
- CPRX Strong Buy
- Analyst Count
- NWE 5
- CPRX 5
- Target Price
- NWE $59.80
- CPRX $32.60
- AVG Volume (30 Days)
- NWE 564.9K
- CPRX 1.4M
- Earning Date
- NWE 10-29-2025
- CPRX 11-05-2025
- Dividend Yield
- NWE 3.87%
- CPRX N/A
- EPS Growth
- NWE N/A
- CPRX 44.94
- EPS
- NWE 3.53
- CPRX 1.71
- Revenue
- NWE $1,569,761,000.00
- CPRX $578,196,000.00
- Revenue This Year
- NWE $6.08
- CPRX $16.59
- Revenue Next Year
- NWE $4.48
- CPRX $8.42
- P/E Ratio
- NWE $19.35
- CPRX $13.71
- Revenue Growth
- NWE 4.90
- CPRX 25.56
- 52 Week Low
- NWE $50.43
- CPRX $19.05
- 52 Week High
- NWE $68.48
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- NWE 73.73
- CPRX 69.16
- Support Level
- NWE $65.40
- CPRX $22.23
- Resistance Level
- NWE $67.23
- CPRX $23.92
- Average True Range (ATR)
- NWE 1.51
- CPRX 0.80
- MACD
- NWE 0.12
- CPRX 0.09
- Stochastic Oscillator
- NWE 99.64
- CPRX 91.23
About NWE NorthWestern Energy Group Inc.
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).